Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Open Access
- 9 February 2024
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 25 (3) , 537-551
Abstract
A nasally delivered chimpanzee adenoviral-vectored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is currently used in India (iNCOVACC). Here, we update this vaccine by creating ChAd-SARS-CoV-2-BA.5-S, which encodes a prefusion-stabilized BA.5 spike protein. Whereas serum neutralizing antibody responses induced by monovalent or bivalent adenoviral vaccines were poor against the antigenically distant XBB.1.5 strain and insufficient to protect in passive transfer experiments, mucosal antibody and cross-reactive memory T cell responses were robust, and protection was evident against WA1/2020 D614G and Omicron variants BQ.1.1 and XBB.1.5 in mice and hamsters. However, depletion of memory CD8+ T cells before XBB.1.5 challenge resulted in loss of protection against upper and lower respiratory tract infection. Thus, nasally delivered vaccines stimulate mucosal immunity against emerging SARS-CoV-2 strains, and cross-reactive memory CD8+ T cells mediate protection against lung infection by antigenically distant strains in the setting of low serum levels of cross-reactive neutralizing antibodies.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI157155, HHSN272201400008C, 75N93021C00014, R01 AI146779, R01 CA211096, 75N93021C00016)
This publication has 86 references indexed in Scilit:
- Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of PneumoniaClinical Chemistry, 2020
- Histopathologic Evaluation and Scoring of Viral Lung Infection2019
- Approaches to Evaluate Lung Inflammation in Translational ResearchVeterinary Pathology, 2017
- Tissue resident memory T cells and viral immunityCurrent Opinion in Virology, 2017
- Vaccine-generated lung tissue–resident memory T cells provide heterosubtypic protection to influenza infectionJCI Insight, 2016
- Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infectionJournal of Leukocyte Biology, 2013
- Cell-mediated Protection in Influenza InfectionEmerging Infectious Diseases, 2006
- Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of MiceThe Journal of Immunology, 2004
- Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.The Journal of Immunology, 1994
- The polypeptides of adenovirusVirology, 1968